Optimizing Functional Recovery After Breast Cancer Treatment
Optimization of a Multicomponent Intervention to Foster Functional Recovery After Breast Cancer Treatment
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests ways to help people return to work, social activities, exercise, and daily tasks after treatment for early-stage breast cancer. Participants will try one of 8 combinations of support that may include choosing priorities, education, and help with setting goals, solving problems, and making plans.
The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer. The main question it aims to answer is: Which of the intervention components, alone or in combination, most effectively promote participation in vocational, social, physical, and instrumental activities of daily living? Participants will be asked to try one of 8 combination of three intervention components that have been shown to promote activity participation: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 18 or older.
- Had Stage 1–3 breast cancer and finished treatment meant to cure it within the past year. The cancer has not come back.
- Have trouble taking part in work and social activities, shown by a score above 10 on the Work and Social Adjustment Scale.
Who can't join
- Do not speak English.
- Have hearing loss that cannot be corrected.
- Have moderate to severe problems with memory or thinking, shown by a score below 3 on a 6-question test.
- Medical records show a history of severe mental illness, such as schizophrenia or bipolar disorder; current major depression; current thoughts of suicide; or current misuse of alcohol or drugs.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. Age of 18 years or older, 2. Diagnosed with Stage 1-3 breast cancer and within one year of completion of locoregional treatment and/or adjuvant therapy with curative intent and absence of disease recurrence, 3. Experiencing reduced participation (i.e., a score of \> 10 on the Work and Social Adjustment Scale). Exclusion Criteria: 1. Non-English speaking. 2. Non-correctable hearing loss. 3. Moderate-severe cognitive impairment indicated by a score \< 3 on a 6-item cognitive screener. 4. History of severe mental illness (i.e., schizophrenia, bipolar disorder), current major depressive disorder, active suicidal ideation, or active substance misuse documented within the medical record.
Study sites (1)
MA
- MGH Institute of Health Professions · Boston, MA 02129Sheel Singh, MA · Study contact · 617-724-9835 · ssingh@mghihp.eduKathleen Lyons, ScD · Study contact · 617-643-5372 · carelab@partners.orgKathleen Lyons, ScD · Principal investigatorMore trials in Boston